Sophia Delicou: Does Hepatic Dysfunction Truly Reflect Thrombotic Risk in Hemoglobinopathies?
Sophia Delicou, Clinical Hematologist and Head of the Thalassemia and Sickle Cell Unit at Hippocration General Hospital Athens, shared on LinkedIn about a recent article she and her colleagues co-authored, adding:
“New scientific publication
We are pleased to share our recent article published in Hematology and Transfusion International Journal, a study originating from the Center of Expertise for Hemoglobinopathies.
The work addresses an issue that is often taken for granted: whether hepatic dysfunction truly reflects thrombotic risk in hemoglobinopathies.
Our findings highlight the complexity of thrombotic risk assessment and underscore the need for a more holistic, multifactorial approach, supported by strong interdisciplinary collaboration.
Sincere thanks to all members of our team for their contribution and commitment.”
Title: Hepatic dysfunction in hemoglobinopathies: a misleading indicator of thrombotic risk?
Authors: Anthimos Papadopoulos, Efrosyni Nomikou, Efthimia Pavlou, Sophia Delicou
Read the Full Article on Hematology and Transfusion International Journal.
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 23, 2026, 17:51Gurpreet Kaurr: A Proud Milestone in Haematology and Oncology
-
Aug 23, 2026, 17:33Kathrine Kaspersen: How Voluntary Plasma Donors Helped Transform Denmark’s Plasma Supply
-
Aug 23, 2026, 16:51Sthanu Subramanian: Empagliflozin and a Rise in Hematocrit
-
Aug 23, 2026, 16:50Lale Tokgözoğlu: New PCSK9i Research Published in the European Heart Journal
-
Aug 23, 2026, 16:44Eric Gehrie: Your 2026 Guide to the Essentials of Transfusion Medicine
-
Aug 23, 2026, 16:35Thomas Dayspring: The Overlooked Pathway in Cholesterol Homeostasis
-
Aug 23, 2026, 16:28Evan Mapelu: The People Who Make Cancer Care Meaningful
-
Aug 23, 2026, 16:09Felice Gragnano: New Publication on Aspirin Discontinuation After PCI for Acute Coronary Syndromes
-
Aug 23, 2026, 16:06Mostafa Faisal: Donor Type and Long-Term Quality of Life After HCT for Severe Aplastic Anemia